Hunter C. Smith

Hunter Smith has served as the chief financial officer and treasurer of Rhythm Pharmaceuticals since 2017 and served as interim chief executive officer from March to July 2020. Prior to joining Rhythm, Hunter was vice president, finance and chief financial officer of Celgene Corporation’s inflammation and immunology business unit where he provided financial and strategic leadership for the global launch of Otezla®. Prior to Celgene, he held roles of increasing responsibility at Bunge Limited,a global food and agribusiness company, including director of investor relations, chief financial officer—Asia, corporate treasurer, and chief financial officer of Bunge's sugar and bioenergy segment. Hunter holds an M.B.A in finance from NYU’s Stern School of Business and a B.A. in history, with honors, from Northwestern University.